Manhattan Scientifics, Inc. (MHTX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
Manhattan Scientifics Market Cap
Manhattan Scientifics has a market cap or net worth of $559.00 as of August 26, 2025. Its market cap has decreased by -99.96% in one year.
Market Cap
559.00
Enterprise Value
1.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 3, 1999, Manhattan Scientifics's market cap has decreased from 37.26M to 559.00, a decrease of -100.00%. That is a compound annual growth rate of -34.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 559.00 | -99.83% |
| Dec 31, 2024 | 335.57K | -76.92% |
| Dec 29, 2023 | 1.45M | -67.50% |
| Dec 30, 2022 | 4.47M | -50.00% |
| Dec 31, 2021 | 8.95M | -62.38% |
| Dec 31, 2020 | 23.79M | 306.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |